Stealth BioTherapeutics Corp. Sponsored ADR Free Cash Flow 2019-2022 | MITO
Stealth BioTherapeutics Corp. Sponsored ADR free cash flow from 2019 to 2022. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Stealth BioTherapeutics Corp. Sponsored ADR Annual Free Cash Flow |
| 2021 |
-45.04 |
| 2020 |
-53.57 |
| 2019 |
-48.11 |
| 2018 |
-72.09 |
| 2017 |
-70.00 |
| Stealth BioTherapeutics Corp. Sponsored ADR Quarterly Free Cash Flow |
| 2022-03-31 |
|
| 2021-12-31 |
-45.04 |
| 2021-09-30 |
|
| 2021-06-30 |
-23.29 |
| 2021-03-31 |
|
| 2020-12-31 |
-53.57 |
| 2020-09-30 |
-43.84 |
| 2020-06-30 |
-32.91 |
| 2020-03-31 |
|
| 2019-12-31 |
-48.11 |
| 2019-09-30 |
-53.44 |
| 2019-06-30 |
|
| 2019-03-31 |
|
| 2018-12-31 |
-72.09 |
| 2018-09-30 |
|
| 2018-06-30 |
|
| 2018-03-31 |
|
